Technical Analysis for MRTX - Mirati Therapeutics, Inc.

Grade Last Price % Change Price Change
D 189.09 4.47% 8.09
MRTX closed down 4.18 percent on Thursday, March 4, 2021, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical MRTX trend table...

Date Alert Name Type % Chg
Stochastic Reached Oversold Weakness 4.47%
Multiple of Ten Bullish Other 4.47%
Below Lower BB Weakness 4.47%
Down 3 Days in a Row Weakness 4.47%
Lower Bollinger Band Touch Weakness 4.47%
Oversold Stochastic Weakness 4.47%
MACD Bearish Signal Line Cross Bearish 0.10%
Multiple of Ten Bearish Other 0.10%
Below Lower BB Weakness 0.10%
Lower Bollinger Band Touch Weakness 0.10%
Older End-of-Day Signals for MRTX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 5% about 2 hours ago
Up 1 ATR about 2 hours ago
Rose Above Previous Day's High about 2 hours ago
Outside Day about 2 hours ago
Up 3% about 3 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Mirati Therapeutics Inc., a biopharmaceutical company, engages in the development of therapeutics for the cancer treatment. Its lead program in clinical development is MGCD265, a multi-targeted small molecule kinase inhibitor for treatment of oncology patients with solid tumors. The company also evaluates development opportunities in oncology for mocetinostat, a spectrum-selective HDAC inhibitor for the treatment of patients with myelodysplastic syndrome or lymphoma; and MGCD516, a kinase inhibitor with a target profile for the treatment of patients with non-small cell lung cancer and other solid tumors. Mirati Therapeutics Inc. is headquartered in San Diego, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Clinical Development Solid Tumors Oncology Chemical Compounds Lymphoma Small Cell Lung Cancer Non Small Cell Lung Cancer Cancer Treatment Targeted Therapy Myelodysplastic Syndrome Bemcentinib

Is MRTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 249.42
52 Week Low 66.01
Average Volume 395,954
200-Day Moving Average 172.05
50-Day Moving Average 209.27
20-Day Moving Average 202.00
10-Day Moving Average 198.12
Average True Range 9.10
ADX 17.45
+DI 14.09
-DI 34.16
Chandelier Exit (Long, 3 ATRs ) 187.14
Chandelier Exit (Short, 3 ATRs ) 206.84
Upper Bollinger Band 216.42
Lower Bollinger Band 187.57
Percent B (%b) -0.23
BandWidth 14.29
MACD Line -4.66
MACD Signal Line -3.35
MACD Histogram -1.3058
Fundamentals Value
Market Cap 8.94 Billion
Num Shares 49.4 Million
EPS -4.19
Price-to-Earnings (P/E) Ratio -43.25
Price-to-Sales 809.26
Price-to-Book 21.13
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 195.20
Resistance 3 (R3) 196.29 192.65 192.83
Resistance 2 (R2) 192.65 189.03 192.10 192.04
Resistance 1 (R1) 186.83 186.80 185.01 185.73 191.25
Pivot Point 183.19 183.19 182.28 182.64 183.19
Support 1 (S1) 177.36 179.57 175.54 176.27 170.75
Support 2 (S2) 173.72 177.34 173.17 169.96
Support 3 (S3) 167.90 173.72 169.17
Support 4 (S4) 166.80